TrialJournal of clinical pharmacology2017

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Elaine Rutherford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.